How did GLYC's revenue and expenses shift in Q4 2024?

Glycomimetics (GLYC) experienced a significant shift in its financial metrics during Q4 2024, with total revenue decreasing, while cost of goods sold, R&D expenses, and sales and marketing expenses increased compared to the previous quarter: |code|Ticker|Name|Date|Cost of Goods Sold|R&D Expenses|Interest Expenses|Total Revenue|Advertising and Marketing Expenses|market_code| |---|---|---|---|---|---|---|---|---|---| |GLYC|GLYC.O|Glycomimetics|2024 Q1||6025461||||186| |GLYC|GLYC.O|Glycomimetics|2024 Q2||6285734||||186| |GLYC|GLYC.O|Glycomimetics|2024 Q3||1715347||||186| |GLYC|GLYC.O|Glycomimetics|2024 Q4||233214||||186|